Literature DB >> 18094014

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients.

P Schelstraete1, S Van Daele, K De Boeck, M Proesmans, P Lebecque, J Leclercq-Foucart, A Malfroot, M Vaneechoutte, F De Baets.   

Abstract

The source of acquisition of Pseudomonas aeruginosa in cystic fibrosis (CF) patients remains unknown. Patient-to-patient transmission has been well documented but the role of the environment as a source of initial infection is as yet unclear. In the present study, the origin of the first P. aeruginosa isolate in CF patients was investigated by comparing the P. aeruginosa genotype(s) from newly infected patients with genotypes of P. aeruginosa isolates from the home environment and from other patients from the same CF centre. A total of 50 newly infected patients were studied. P. aeruginosa could be cultured from 5.9% of the environmental samples, corresponding to 18 patients. For nine of these, the genotype of the environmental P. aeruginosa isolate was identical to the patient's isolate. In total, 72% of the environmental P. aeruginosa isolates were encountered in the bathroom. Patient-to-patient transmission within the CF centre could not be ruled out for three patients. In summary, a low prevalence of Pseudomonas aeruginosa was found in the home environment of the newly infected cystic fibrosis patients. The bathroom should be targeted in any preventive cleaning procedures. An environmental source of the new infection could not be ruled out in nine patients.

Entities:  

Mesh:

Year:  2007        PMID: 18094014     DOI: 10.1183/09031936.00088907

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  Interference Competition Among Household Strains of Pseudomonas.

Authors:  Michael T France; Susanna K Remold
Journal:  Microb Ecol       Date:  2015-08-16       Impact factor: 4.552

2.  Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.

Authors:  Chloé Dupont; Estelle Jumas-Bilak; Clara Doisy; Fabien Aujoulat; Raphaël Chiron; Hélène Marchandin
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

3.  Transcriptional Responses of Pseudomonas aeruginosa to Potable Water and Freshwater.

Authors:  Erika L English; Kristin C Schutz; Graham G Willsey; Matthew J Wargo
Journal:  Appl Environ Microbiol       Date:  2018-03-01       Impact factor: 4.792

4.  Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.

Authors:  Michael D Parkins; Bryan A Glezerson; Christopher D Sibley; Kristen A Sibley; Jessica Duong; Swathi Purighalla; Christopher H Mody; Matthew L Workentine; Douglas G Storey; Michael G Surette; Harvey R Rabin
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

5.  General and inducible hypermutation facilitate parallel adaptation in Pseudomonas aeruginosa despite divergent mutation spectra.

Authors:  Michael R Weigand; George W Sundin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

6.  Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Sally Palser; Sherie Smith; Edward F Nash; Arnav Agarwal; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

7.  Differential habitat use and niche partitioning by Pseudomonas species in human homes.

Authors:  Susanna K Remold; Christopher K Brown; Justin E Farris; Thomas C Hundley; Jessica A Perpich; Megan E Purdy
Journal:  Microb Ecol       Date:  2011-04-19       Impact factor: 4.552

8.  Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients.

Authors:  Thomas Bjarnsholt; Peter Østrup Jensen; Tim Holm Jakobsen; Richard Phipps; Anne Kirstine Nielsen; Morten Theil Rybtke; Tim Tolker-Nielsen; Michael Givskov; Niels Høiby; Oana Ciofu
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

9.  Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.

Authors:  Lucie Amoureux; Julien Bador; Sakina Fardeheb; Cédric Mabille; Charlyne Couchot; Clémence Massip; Anne-Lise Salignon; Guillaume Berlie; Véronique Varin; Catherine Neuwirth
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

10.  Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients.

Authors:  Pieter Deschaght; Thierry De Baere; Leen Van Simaey; Sabine Van Daele; Frans De Baets; Daniel De Vos; Jean-Paul Pirnay; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2009-11-29       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.